APR 11, 2018 9:00 AM PDT

Conversion of Group A Streptococcus Confirmation Testing from Culture to Molecular: Automation, Workflow Improvements and Antimicrobial Stewardship

Sponsored by: DiaSorin Inc.
Speaker
  • Division Director for "Molecular and Microbial Diagnostics and Development", Department of Laboratory Medicine, Geisinger
    Biography
      Dr. Wolk serves as the Division Director for “Molecular and Microbial Diagnostics and Development” in the Department of Laboratory Medicine at Geisinger, an integrated healthcare delivery network serving ~ 3 million people in Central PA.                                                                            A Diplomate of the American Board of Medical Microbiology (ABMM), Dr. Wolk's professional practice extends to the national and international level. She serves on CLIAC, providing scientific and technical guidance to the US Dept. of Health and Human Services, and serves as a liaison to the CDC's Board of Scientific Counselors for the Office of Infectious Diseases. She is the Diagnostic Microbiology Lead for Project Santa Fe's Clinical Laboratory 2.0 initiatives and was recently elected as incoming chair of the Infectious Disease subdivision for the Association of Molecular Pathology. Dr. Wolk is the lead investigator for Geisinger's Center for Laboratory Innovations and Outcomes, and chair of the Diagnostic Medicine Institute's Clinical Research Council. Her translational research efforts focus on evaluation and evidence-based integration of new technology for infectious disease diagnostics, and she leads the ASM/Center for Disease Control's Laboratory Medicine Best Practice initiatives to characterize the rapid diagnosis of bacteremia, and is a Professor at Geisinger Commonwealth School of Medicine. In 2012, she was awarded the 1885 Society's Distinguished Scholar's Award at the University of Arizona; in 2016 she received the American Society for Microbiology's BD Award for Clinical Research in Microbiology; in 2018, her career was highlighted in the ASM Press book entitled “Women in Microbiology.” Dr. Wolk's post-doctoral fellowship was in Medical and Public Health Microbiology at Mayo Clinic, her Ph.D. was awarded in Pathobiology at the University of Arizona, and she earned a Master's in Health Administration from Wilkes University, with a B.S. in Microbiology/ Medical Technology from Penn State University.

    Abstract

    Streptococcus pyogenes or Group A Streptococcus (GAS) is a pathogenic bacteria that causes both invasive and non-invasive infections resulting in mild to severe life-threatening disease.

    Laboratory guidelines mandate that a more sensitive confirmatory test is performed on negative rapid antigen samples. However, routine culture detection of the organism can take an additional 24-48 hours. As an alternative, rapid molecular testing for Group A Strep can offer a faster and more efficient method for confirmation, contributing to the accelerated treatment of the patient.

    During this presentation you will learn how our laboratory implemented a rapid, automated highthroughput method for molecular confirmation of rapid antigen negatives. The advantages of moving this assay from culture to molecular in terms of workflow and increased sensitivity will be discussed.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    APR 20, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 20, 2021 11:00 AM PDT
    Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    APR 08, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 08, 2021 11:00 AM PDT
    Date: April 8, 2021 Time: 11:00am (PDT), 3:00pm (EDT) Pneumonia is a deadly condition with clinical outcomes highly dependent on prompt and appropriate therapy. Diagnosis of pneumonia is cha...
    APR 11, 2018 9:00 AM PDT

    Conversion of Group A Streptococcus Confirmation Testing from Culture to Molecular: Automation, Workflow Improvements and Antimicrobial Stewardship

    Sponsored by: DiaSorin Inc.

    Specialty

    Research And Development

    Cell Biology

    Earth Science

    University

    Clinical Lab

    Animal Models

    Research

    Cancer Research

    Health

    Geography

    North America67%

    Asia33%

    Registration Source

    Website Visitors100%

    Job Title

    Executive33%

    Clinical Laboratory Scientist33%

    Medical Laboratory Technician33%

    Organization

    Manufacturer - Other33%

    Hospital33%

    Independent Laboratories33%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more